Asset Dedication, LLC Eli Lilly & CO Transaction History

Asset Dedication, LLC

$1.46 Billion
Q3 2024

A detailed history of Asset Dedication, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Asset Dedication, LLC holds 7,265 shares of LLY stock, worth $5.49 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

7,265

Previous 8,693 16.43%

Holding current value

$5.49 Million

Previous $7.87 Million 18.22%

% of portfolio

0.44%

Previous 0.55%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $1.1 Million - $1.37 Million	-1,428 Reduced 16.43%	7,265 $6.44 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $254,429 - $319,073	351 Added 4.21%	8,693 $7.87 Million
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $601,083 - $804,164	-1,015 Reduced 10.85%	8,342 $6.49 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $473,196 - $557,836	901 Added 10.66%	9,357 $5.44 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $72,160 - $99,483	166 Added 2.0%	8,456 $4.57 Million
Q2 2023 Aug 21, 2023	BUY	$350.74 - $468.98 $238,503 - $318,906	680 Added 8.94%	8,290 $3.86 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $1.57 Million - $1.84 Million	5,045 Added 196.69%	7,610 $2.61 Million
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $202,254 - $235,667	629 Added 32.49%	2,565 $944,000
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $573,985 - $654,116	1,936 New	1,936 $625,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $466,594 - $547,849	-1,674 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $49,050 - $60,956	-209 Reduced 11.1%	1,674 $480,000
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $60,934 - $75,619	271 Added 16.81%	1,883 $519,000
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $47,422 - $58,359	214 Added 15.31%	1,612 $373,000
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $30,512 - $39,468	169 Added 13.75%	1,398 $322,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $59,319 - $76,791	-361 Reduced 22.7%	1,229 $228,000
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $4,827 - $6,387	-37 Reduced 2.27%	1,590 $267,000
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $30,121 - $34,840	206 Added 14.5%	1,627 $241,000
Q2 2020 Aug 24, 2020	SELL	$136.42 - $164.18 $15,551 - $18,716	-114 Reduced 7.43%	1,421 $233,000
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $81,073 - $100,345	681 Added 79.74%	1,535 $215,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $42,768 - $52,972	400 Added 88.11%	854 $112,000
Q3 2019 Oct 17, 2019	BUY	$106.79 - $116.16 $38,230 - $41,585	358 Added 372.92%	454 $52,000
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $44,316 - $51,728	-400 Reduced 80.65%	96 $11,000
Q1 2019 Apr 19, 2019	SELL	$111.31 - $131.02 $1,780 - $2,096	-16 Reduced 3.13%	496 $64,000
Q1 2018 Apr 19, 2018	BUY	$74.21 - $87.6 $23,821 - $28,119	321 Added 168.06%	512 $40,000
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $14,720 - $16,338	191	191 $17,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Account

Asset Dedication, LLC Eli Lilly & CO Transaction History